Emmanuel B. Walter

11.7k total citations · 6 hit papers
131 papers, 5.2k citations indexed

About

Emmanuel B. Walter is a scholar working on Epidemiology, Infectious Diseases and Health. According to data from OpenAlex, Emmanuel B. Walter has authored 131 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Epidemiology, 38 papers in Infectious Diseases and 21 papers in Health. Recurrent topics in Emmanuel B. Walter's work include Influenza Virus Research Studies (44 papers), Respiratory viral infections research (36 papers) and Vaccine Coverage and Hesitancy (21 papers). Emmanuel B. Walter is often cited by papers focused on Influenza Virus Research Studies (44 papers), Respiratory viral infections research (36 papers) and Vaccine Coverage and Hesitancy (21 papers). Emmanuel B. Walter collaborates with scholars based in United States, Australia and South Korea. Emmanuel B. Walter's co-authors include Lisa A. Grohskopf, Karen R. Broder, Alicia M. Fry, Daniel B. Jernigan, Leslie Z. Sokolow, Joseph Bresee, Janet A. Englund, M. Anthony Moody, Geeta K. Swamy and Elif Alyanak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and PLoS ONE.

In The Last Decade

Emmanuel B. Walter

123 papers receiving 5.1k citations

Hit Papers

Prevention and Control of Seasonal Influenza with Vaccine... 2014 2026 2018 2022 2018 2014 2019 2017 2022 250 500 750 1000

Peers

Emmanuel B. Walter
Fiona van der Klis Netherlands
Flor M. Muñoz United States
Joon Young Song South Korea
Rafael Harpaz United States
Harry Keyserling United States
Paul Gargiullo United States
Lisa A. Grohskopf United States
Emmanuel B. Walter
Citations per year, relative to Emmanuel B. Walter Emmanuel B. Walter (= 1×) peers Odile Launay

Countries citing papers authored by Emmanuel B. Walter

Since Specialization
Citations

This map shows the geographic impact of Emmanuel B. Walter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel B. Walter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel B. Walter more than expected).

Fields of papers citing papers by Emmanuel B. Walter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel B. Walter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel B. Walter. The network helps show where Emmanuel B. Walter may publish in the future.

Co-authorship network of co-authors of Emmanuel B. Walter

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel B. Walter. A scholar is included among the top collaborators of Emmanuel B. Walter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel B. Walter. Emmanuel B. Walter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenberg, Rachel G., Wes Rountree, Mary Allen Staat, et al.. (2025). Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants. JAMA Pediatrics. 179(3). 246–246.
2.
Suh, Mina, Emmanuel B. Walter, Charles T. Wood, et al.. (2024). Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID‐19: Results From Four Health Systems, 2015–2023. Influenza and Other Respiratory Viruses. 18(5). e13298–e13298. 1 indexed citations
3.
Walter, Emmanuel B., Elizabeth P. Schlaudecker, Kawsar R. Talaat, et al.. (2024). Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines. JAMA Network Open. 7(11). e2443166–e2443166. 6 indexed citations
4.
Hu, Xintao, Sarah Valencia, Jennifer A. Jenks, et al.. (2024). Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine. The Journal of Infectious Diseases. 230(2). 455–466. 48 indexed citations breakdown →
5.
Suh, Mina, Emmanuel B. Walter, Charles T. Wood, et al.. (2024). Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023. Annals of Epidemiology. 94. 72–80. 2 indexed citations
6.
Ortiz, Justin R., David I. Bernstein, Daniel F. Hoft, et al.. (2023). A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults. The Journal of Infectious Diseases. 228(3). 287–298. 6 indexed citations
7.
Jackson, Lisa A., Jack T. Stapleton, Emmanuel B. Walter, et al.. (2023). Immunogenicity and safety of varying dosages of a fifth-wave influenza A/H7N9 inactivated vaccine given with and without AS03 adjuvant in healthy adults. Vaccine. 42(2). 295–309. 2 indexed citations
8.
Sawant, Sheetal, R. Glenn Overman, Thomas H. Oguin, et al.. (2023). H3N2 influenza hemagglutination inhibition method qualification with data driven statistical methods for human clinical trials. Frontiers in Immunology. 14. 1155880–1155880. 4 indexed citations
9.
10.
Jenks, Jennifer A., Cody S. Nelson, Robert F. Pass, et al.. (2020). Antibody binding to native cytomegalovirus glycoprotein B predicts efficacy of the gB/MF59 vaccine in humans. Science Translational Medicine. 12(568). 32 indexed citations
11.
Kemper, Alex R., Elizabeth D. Barnett, Emmanuel B. Walter, et al.. (2017). Drinking Water to Prevent Postvaccination Presyncope in Adolescents: A Randomized Trial. PEDIATRICS. 140(5). 7 indexed citations
12.
Walter, Emmanuel B., et al.. (2016). State-Level Immunization Information Systems: Potential for Childhood Immunization Data Linkages. Maternal and Child Health Journal. 21(1). 29–35. 13 indexed citations
13.
Kotloff, Karen L., Natasha Halasa, Christopher J Harrison, et al.. (2014). Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children. The Pediatric Infectious Disease Journal. 33(8). 865–871. 8 indexed citations
14.
Frey, Sharon E., Patricia Winokur, Robert A. Salata, et al.. (2013). Safety and immunogenicity of IMVAMUNE® smallpox vaccine using different strategies for a post event scenario. Vaccine. 31(29). 3025–3033. 50 indexed citations
15.
Blaney, Nancy T., Mercedes Fernández, Kathleen A. Ethier, et al.. (2004). Psychosocial and Behavioral Correlates of Depression Among HIV-Infected Pregnant Women. AIDS Patient Care and STDs. 18(7). 405–415. 80 indexed citations
16.
Benjamin, Danny, et al.. (2004). Growth Patterns Reflect Response to Antiretroviral Therapy in HIV-Positive Infants: Potential Utility in Resource-Poor Settings. AIDS Patient Care and STDs. 18(1). 35–43. 7 indexed citations
17.
Clark, H. F., Carl J. Burke, David B. Volkin, et al.. (2003). Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation. The Pediatric Infectious Disease Journal. 22(10). 914–920. 51 indexed citations
18.
Wilson, Tracey E., Jeannette R. Ickovics, Mercedes Fernández, Linda J. Koenig, & Emmanuel B. Walter. (2001). Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. American Journal of Obstetrics and Gynecology. 184(6). 1235–1240. 26 indexed citations
19.
Napravnik, Sonia, et al.. (2000). HIV-1 Infected Women and Prenatal Care Utilization: Barriers and Facilitators. AIDS Patient Care and STDs. 14(8). 411–420. 39 indexed citations
20.
Walter, Emmanuel B., et al.. (1998). How do North Carolina prenatal care providers counsel and test pregnant women for HIV? Survey measures knowledge of HIV testing benefits.. PubMed. 59(2). 105–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026